Volume 36, 2000, Issue 43
IDE Technology 50% off
Yossi Rosen, chairman of Israel Chemicals, gave rationale for 50% sale of IDE Technologies to Delek Investments and Properties, saying Israel's...
Yossi Rosen, chairman of Israel Chemicals, gave rationale for 50% sale of IDE Technologies to Delek Investments and Properties, saying Israel's...